FDA Approved: DASATINIB — Original Application (Biocon Pharma Inc.)

View source ↗

Summary

FDA approves Biocon Pharma Inc.'s original application for dasatinib (generic) to treat certain leukemias, marking the availability of a generic version of the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Chronic Myeloid Leukemia

Drugs mentioned

• DASATINIB (Dasatinib)

Snippet

ORIG AP for DASATINIB (DASATINIB)